Identification of pharmacogenetic markers in smoking cessation therapy. - Wikidata - wikimedia - TriplyDB

Identification of pharmacogenetic markers in smoking cessation therapy.

Identification of pharmacogenetic markers in smoking cessation therapy.

http://www.wikidata.org/entity/Q37127185

about

Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use Translational research in nicotine dependence Significant associations of CHRNA2 and CHRNA6 with nicotine dependence in European American and African American populations Determination of allelic expression of SNP rs1880676 in choline acetyltransferase gene in HeLa cells Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.Multiplicity-calibrated Bayesian hypothesis tests.Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD.Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors.Genetic linkage findings for DSM-IV nicotine withdrawal in two populations.Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.Biomarkers to optimize the treatment of nicotine dependence.Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.Neuroimaging, genetics and the treatment of nicotine addiction Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.The CHRNA5-A3-B4 gene cluster in nicotine addiction.PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases.An essential role of acetylcholine-glutamate synergy at habenular synapses in nicotine dependence.Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence The value of control conditions for evaluating pharmacogenetic effects.Risk gene variants for nicotine dependence: a success story in neuropsychiatric genetics with possible applications to drug development.Effects of tetrahydropalmatine on post-traumatic stress disorder-induced changes in rat brain gene expression.Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Effect of the rs1051730–rs16969968 variant and smoking cessation treatment: a meta-analysis

P2860

Q26782271-253B3944-8F60-41EF-93F7-7BF0F3F8DA7D Q26852485-DC14A8E6-2D40-40A4-9EEF-400071D4D90C Q30405502-8A16001B-F90E-46D7-A4AC-B9B3041FF6A4 Q30409958-07A1C339-AA59-4146-A3DC-16D7E686BCC5 Q30434359-935976DE-2AAB-455A-9150-160A440C7CBD Q34030764-D82C2565-7737-4F59-967A-29ECFB0B4C50 Q34206203-FB9B6398-E04E-468A-BA80-7A14B4D40185 Q34342415-D6521032-FDC5-4823-88BD-6D04B5F3206C Q34373128-58D3722C-EDA5-44C5-A242-8EA463416D86 Q35679980-A0CA1192-6929-4AD1-9B3D-8E98EC684183 Q35751986-AB706D52-7CFB-4970-A83F-8403DFB1E458 Q35773685-71C67B5C-068D-4A8D-B592-B9B1DC92F4FB Q36286817-71F2ACAC-433A-42B9-A1E4-F65233113FBE Q36585530-D7F2F1D9-29E6-49CF-AC8D-90B472695C2C Q36851620-F874DF94-CCD4-4A53-A32B-D07619844B6A Q37010016-B1E4BE8D-915C-4983-AF7E-93EB1C3D7144 Q37395740-1FE761C5-5BAE-4723-9BF8-922D973739F1 Q37535489-ADFD6218-15C6-4D56-8B0F-7872AAF3295D Q37942053-284BCECC-CBC6-40B9-A8D4-B3D9D11B1EE5 Q38664551-A70D54AB-C1CF-4BD5-A162-CF4337E8EA42 Q40256866-684A890F-3A23-46AB-BA53-70535B02CB25 Q41636544-9B12817A-4A93-42DE-BFE0-F29ACF7D74E6 Q42346078-B853849A-40B3-4EEC-BDEC-6BBC16FE336E Q42837775-69AA5284-709A-4823-AA84-C2F24DDA7E9A Q43553777-18AD2528-271F-4139-B3B1-4BB2DD9C4A21 Q47551037-4BE82762-1EC5-4665-B997-15BC686BF3CC Q48015634-55BB2A03-AAC0-416F-8DF3-616D0F0AD6DB Q59196333-141CFB7C-0AEB-47CD-808D-CDF7A3E54934

P2860

Identification of pharmacogenetic markers in smoking cessation therapy.

http://www.wikidata.org/entity/Q37127185

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Identification of pharmacogenetic markers in smoking cessation therapy.

@en

Identification of pharmacogenetic markers in smoking cessation therapy.

@nl

type

label

Identification of pharmacogenetic markers in smoking cessation therapy.

@en

Identification of pharmacogenetic markers in smoking cessation therapy.

@nl

prefLabel

Identification of pharmacogenetic markers in smoking cessation therapy.

@en

Identification of pharmacogenetic markers in smoking cessation therapy.

@nl

P1433

Q37127185-DE724541-B756-4F36-9B0B-FCF82B5E92D0

P1476

Q37127185-F2D040B6-89CC-403B-A683-6EB18810263B

P2093

Q37127185-2F6E6FF5-C278-4C72-85DC-2217B202D5B8

Q37127185-5F697DB8-0414-41AB-ADE8-E98293D2EA34

Q37127185-962F7F79-530D-498C-B3F4-391649DE8E4F

Q37127185-D25198EF-1E0B-494F-892C-CE9BF0BA5D91

Q37127185-E460B9D3-5675-4E58-AA53-1C548D06AFB1

P2860

Q37127185-006734C3-8D34-46D8-B5F9-16391E9DA1AA

Q37127185-02986FC2-6AC3-42CF-85B2-C70BC3683A64

Q37127185-0D5ECCE8-4B91-4EE5-B987-2BD7E234A248

Q37127185-0E0AE001-0312-4E9B-9128-4754F49AA5E6

Q37127185-111A250B-572D-4ACB-8BF1-1E3372456DE7

Q37127185-1168D565-A883-4DD0-9171-575F193F7831

Q37127185-124716D7-D573-472F-BD29-01AC85447930

Q37127185-20390E5D-406B-45B7-A6A3-50817DF76A82

Q37127185-292C0E92-4650-48C6-BDCB-5D80A71DFD62

Q37127185-2CD02844-6DF4-48EA-893C-93BFE1C84D34

P304

Q37127185-8CADF27B-0717-4018-8EA5-AAABBA54633F

P31

Q37127185-C9C827C7-1D27-4643-8A40-10F546DF7213

P356

Q37127185-7752AE1A-53B2-4F4B-A72A-A61329C288ED

P433

Q37127185-CA605DB8-3167-4856-AED1-D8DAF6778979

P478

Q37127185-CF2D5C0D-48E2-4A6F-A5E5-D76EE836C912

P50

Q37127185-757B8B07-51C7-4164-851E-5F460875203F

P577

Q37127185-CBA3A409-2698-4D2F-9695-09C0EA40266A

P5875

Q37127185-0949D43A-8D1B-498C-834B-1D6917EE3F26

P698

Q37127185-A0D61D43-42B7-4082-A6A6-D864AA4290DD

P932

Q37127185-C6B793C2-C738-4C48-9059-B5380BE9005D

P356

P1433

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

P1476

Identification of pharmacogenetic markers in smoking cessation therapy.

@en

P2093

Daniel F Heitjan

http://www.w3.org/2001/XMLSchema#string

E Paul Wileyto

http://www.w3.org/2001/XMLSchema#string

Leonard H Epstein

http://www.w3.org/2001/XMLSchema#string

Mengye Guo

http://www.w3.org/2001/XMLSchema#string

Riju Ray

http://www.w3.org/2001/XMLSchema#string

P2860

Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits

A new mixture model approach to analyzing allelic-loss data using Bayes factors

Behavioral and biochemical investigations of bupropion metabolites

Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2)

Novel genes identified in a high-density genome wide association study for nicotine dependence

Exploratory Bayesian model selection for serial genetics data.

A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men.

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.

Bupropion is a nicotinic antagonist.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

P304

712-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.B.30669

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

147B

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5683615

http://www.w3.org/2001/XMLSchema#string

P698

18165968

http://www.w3.org/2001/XMLSchema#string

P932

2655206

http://www.w3.org/2001/XMLSchema#string